Theravance Biopharma, Inc. - Ordinary Shares (TBPH): Price and Financial Metrics

Theravance Biopharma, Inc. - Ordinary Shares (TBPH): $9.46

0.12 (+1.28%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add TBPH to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#66 of 362

in industry

TBPH Price/Volume Stats

Current price $9.46 52-week high $11.98
Prev. close $9.34 52-week low $8.21
Day low $9.25 Volume 309,740
Day high $9.47 Avg. volume 384,055
50-day MA $9.02 Dividend yield N/A
200-day MA $9.63 Market Cap 459.38M

TBPH Stock Price Chart Interactive Chart >


Theravance Biopharma, Inc. - Ordinary Shares (TBPH) Company Bio


Theravance Biopharma, Inc. engages in the research and development activities focusing on the diseases of the lung and gastrointestinal tract, and infectious diseases, as well as on the acute care setting markets. The company was founded in 2013 and is based in George Town, the Cayman Islands.


TBPH Latest News Stream


Event/Time News Detail
Loading, please wait...

TBPH Latest Social Stream


Loading social stream, please wait...

View Full TBPH Social Stream

Latest TBPH News From Around the Web

Below are the latest news stories about THERAVANCE BIOPHARMA INC that investors may wish to consider to help them evaluate TBPH as an investment opportunity.

7 Short-Squeeze Stocks That Are Screaming for Speculation

While the concept of short-squeeze stocks has been all the rage throughout most of the pandemic-disruption cycle, we may have been doing this all wrong.

Josh Enomoto on InvestorPlace | December 24, 2023

Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors

Theravance Biopharma, Inc. ("Theravance" or the "Company") (NASDAQ: TBPH) today announced the appointment to its Board of Directors of Jeremy Grant, who serves as a Special Advisor to Irenic Capital Management LP ("Irenic"). With the addition of Mr. Grant, Theravance has appointed four new directors to the Board since 2020.

Yahoo | December 21, 2023

Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that members of its management team including Rick E Winningham, CEO, and Aziz Sawaf, CFO, will hold investor meetings during the 42nd Annual J.P. Morgan Healthcare Conference, January 8-11, 2024, in San Francisco, CA.

Yahoo | December 18, 2023

The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable

Generally speaking long term investing is the way to go. But no-one is immune from buying too high. Zooming in on an...

Yahoo | December 9, 2023

Theravance Bio (TBPH) Up 2.5% Since Last Earnings Report: Can It Continue?

Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 7, 2023

Read More 'TBPH' Stories Here

TBPH Price Returns

1-mo 6.05%
3-mo -4.73%
6-mo 2.60%
1-year -18.17%
3-year -55.27%
5-year -59.28%
YTD -15.84%
2023 0.18%
2022 1.54%
2021 -37.82%
2020 -31.36%
2019 1.17%

Continue Researching TBPH

Here are a few links from around the web to help you further your research on Theravance Biopharma Inc's stock as an investment opportunity:

Theravance Biopharma Inc (TBPH) Stock Price | Nasdaq
Theravance Biopharma Inc (TBPH) Stock Quote, History and News - Yahoo Finance
Theravance Biopharma Inc (TBPH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!